Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Inhalation Anesthesia Market from 2024 to 2025?

In recent times, there’s been a substantial growth in the market size of inhalation anesthesia. The market, which is set to rise from $1.54 billion in 2024 to $1.65 billion in 2025, expects a 6.9% compound annual growth rate (CAGR). Various factors have contributed to this growth during the historic period, including an increase in surgical procedures that require anesthesia, a rise in the geriatric population, advances in inhalation anesthetics, the growth of ambulatory surgical centers, and a surge in chronic diseases like heart disease and cancer.

What Is the Projected Market Size of the Inhalation Anesthesia Market?

The market size of inhalation anesthesia is set to witness substantial growth in the coming years, with a projected value of $2.34 billion in 2029, reflecting a 9.1% compound annual growth rate (CAGR). This anticipated growth, spanning the forecast period, is due to the rising demand for less invasive surgical procedures, escalating worldwide health expenditure, burgeoning surgical procedures in emerging markets, the incorporation of inhalation anesthesia in veterinary medicine, as well as increased public funding for r&d of novel inhalation anesthetics. Noteworthy trends for the forecast period range from technological advances in anesthesia delivery systems, the creation of inhalation anesthesia apparatus specifically for children’s use, a shift towards the use of sevoflurane and desflurane, a focus on environmentally friendly anesthetic agents, to the integration of surveillance technologies in anesthesia delivery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp

Who are the Major Competitors in the Inhalation Anesthesia Market Outlook?

Major companies operating in the inhalation anesthesia market include Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

What Is Fueling Growth in the Inhalation Anesthesia Market?

The growth of the inhalation anesthesia market is projected to be driven by the rise in the elderly population during the forecast period. As geriatric individuals are more likely to develop degenerative diseases and chronic conditions, this leads to a surge in surgical procedures and therapeutic measures, consequently fueling the inhalation anesthesia market. Furthermore, this population group is more prone to a range of health conditions including cardiovascular, neurological, respiratory, and degenerative disorders, which are additional market growth factors. Administering anesthesia intravenously to older patients is often challenging due to issues such as blood vessel punctures and patient compliance problems. The World Health Organization, a Switzerland-based global public health body, reported in October 2022 that the population of individuals aged 60 years and above is set to rise from 1 billion in 2020 to 1.4 billion in 2022. Furthermore, by 2030, one in every six people worldwide will be over the age of 60. It is anticipated, therefore, that the growing older population will spur demand for inhalation anesthesia in the coming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7198&type=smp

Which Inhalation Anesthesia Market Segments Are Growing the Fastest?

The inhalation anesthesia market covered in this report is segmented –

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide

2) By Application: Induction, Maintenance

3) By End User: Hospitals, Ambulatory Surgical Centers

Subsegments:

1) By Sevoflurane: Liquid Form, Gas Form

2) By Desflurane: Liquid Form, Gas Form

3) By Isoflurane: Liquid Form, Gas Form

4) By Nitrous Oxide: Medical-Grade Nitrous Oxide, Industrial-Grade Nitrous Oxide

Which Industry Trends Are Shaping the Future of the Inhalation Anesthesia Market?

Several businesses within the inhalation anesthesia realm are progressing by introducing groundbreaking products, such as Sedaconda, to respond to industry requirements and fortify their global market standing. Sedaconda is a unique sedation therapy administered through the Anaesthetic Conserving Device (ACD) and has the sanction for use in critical care environments. As an example, Sedana Medical AB, a medical technology and pharmaceutical firm based in Sweden, brought Sedaconda (isoflurane) to the German market in February 2022. This product utilizes Sedaconda ACD, a specialized medical apparatus, to deliver isoflurane and is the only authorized inhaled sedation therapy for intensive care situations. After obtaining European DCP consent in July 2021, Sedaconda (isoflurane) has now been nationally approved in 14 countries.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Which Countries Are Leading the Inhalation Anesthesia Market?

North America was the largest region in the inhalation anesthesia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7198

This Report Delivers Insight On:

1. How big is the inhalation anesthesia market, and how is it changing globally?

2. Who are the major companies in the inhalation anesthesia market, and how are they performing?

3. What are the key opportunities and risks in the inhalation anesthesia market right now?

4. Which products or customer segments are growing the most in the inhalation anesthesia market?

5. What factors are helping or slowing down the growth of the inhalation anesthesia market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model